Biomérieux
Company Snapshot
Company Overview
bioMérieux focuses on diagnostic solutions (reagents, instruments, software, and services) to determine the source of disease and contamination, thereby improving patient health and ensuring product safety. It operates in the biomarker landscape, including the central nervous system (CNS) segment, by developing diagnostic tools that enable earlier detection, accurate assessment, and monitoring of neurological conditions. In the CNS domain, it focuses on advanced immunoassay and molecular diagnostic techniques to quantify biomarkers that indicate brain injury or neurological dysfunction. These solutions are intended to support clinicians in evaluating patients with suspected neurological conditions, including mild traumatic brain injury and CNS infections, by providing objective, measurable data to guide treatment decisions and reduce reliance on more invasive or resource-intensive diagnostic procedures.
Financial Highlights (FY 2025)
This information is available for BCC Research members only.
Biomérieux In News
Company's Business Segments
- Clinical Applications : Immunoassays, Molecular biology, Microbiology, and Other ranges.
- Industrial Applications : Food and Pharma Quality Control
Applications/End User Industries
- Hospitals
- Laboratory
- Point Of Care
- Food Safety & Quality
- Pharma Quality Control
- Product Quality & Safety
- Customer Service
- Cybersecurity